FDA Inspection
Owen Biosciences Inc.Owen Biosciences Inc. – FDA Inspection, Mar 27, 2025
Record Details
This FDA Inspection record concerns Owen Biosciences Inc., with an inspection on March 27, 2025, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 6ac663c3-2890-4841-8c41-673cdc955488
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1265549
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(e)Stability testing records not included
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.166(a)(4)Testing in same container - closure system
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Owen Biosciences Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2026 | Not classified | New Orleans District Office | Drug Quality Assurance |
| February 14, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 14, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2011 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Owen Biosciences Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.